Cardlytics Return on Sales vs Current Liabilities Analysis
CDLX Stock | USD 11.94 0.24 1.97% |
Trend analysis of Cardlytics balance sheet accounts such as Short Long Term Debt Total of 138.7 M, Other Current Liabilities of 126 M or Total Current Liabilities of 135.4 M provides information on Cardlytics' total assets, liabilities, and equity, which is the actual value of Cardlytics to its prevalent stockholders. By breaking down trends over time using Cardlytics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Cardlytics |
About Cardlytics Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Cardlytics at a specified time, usually calculated after every quarter, six months, or one year. Cardlytics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cardlytics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cardlytics currently owns. An asset can also be divided into two categories, current and non-current.
Cardlytics Balance Sheet Chart
Cardlytics Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Cardlytics uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Cardlytics' Net Tangible Assets are fairly stable compared to the past year. Property Plant And Equipment Net is likely to rise to about 14.5 M in 2024, whereas Total Assets are likely to drop slightly above 440 M in 2024. Add Fundamental
Total Assets
Total assets refers to the total amount of Cardlytics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cardlytics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Cardlytics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Cardlytics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Cardlytics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cardlytics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.Tax Provision is likely to rise to 0.00 in 2024, whereas Selling General Administrative is likely to drop slightly above 48.4 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 35.7M | 43.7M | 29.5M | 16.8M | Interest Income | 297K | 1.4M | 3.8M | 3.4M |
Cardlytics fundamental ratios Correlations
Click cells to compare fundamentals
Cardlytics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cardlytics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 224.3M | 422.5M | 1.3B | 691.2M | 574.1M | 440.0M | |
Short Long Term Debt Total | 37K | 188.1M | 197.2M | 235.3M | 266.1M | 138.7M | |
Other Current Liab | 76.0M | 74.8M | 313.4M | 238.5M | 162.2M | 126.0M | |
Total Current Liabilities | 78.4M | 81.3M | 327.4M | 248.9M | 171.1M | 135.4M | |
Total Stockholder Equity | 143.3M | 157.2M | 690.7M | 211.6M | 134.8M | 98.0M | |
Other Liab | 2.6M | 679K | 54.5M | 334K | 384.1K | 364.9K | |
Net Tangible Assets | 139.1M | 150.4M | (190.5M) | 158.1M | 181.8M | 190.9M | |
Property Plant And Equipment Net | 14.3M | 24.6M | 21.5M | 12.5M | 10.6M | 14.5M | |
Current Deferred Revenue | 1.1M | 349K | 3.3M | 1.8M | 2.4M | 1.3M | |
Net Debt | (104.4M) | (105.1M) | (36.2M) | 113.4M | 174.3M | 183.0M | |
Retained Earnings | (338.6M) | (394.1M) | (522.6M) | (976.6M) | (1.1B) | (1.1B) | |
Accounts Payable | 1.2M | 1.4M | 4.6M | 3.8M | 4.4M | 3.2M | |
Cash | 104.5M | 293.2M | 233.5M | 121.9M | 91.8M | 116.8M | |
Non Current Assets Total | 28.6M | 36.9M | 905.1M | 441.2M | 350.2M | 226.1M | |
Non Currrent Assets Other | 10.1M | 5.6M | 2.4M | 2.6M | 2.7M | 2.6M | |
Other Assets | 10.1M | 22.6M | 2.4M | 2.6M | 2.3M | 2.2M | |
Long Term Debt | 13K | 174.0M | 184.4M | 226.0M | 257.6M | 130.8M | |
Cash And Short Term Investments | 104.5M | 293.2M | 233.5M | 121.9M | 91.8M | 116.8M | |
Net Receivables | 85.4M | 86.6M | 117.2M | 120.1M | 126.0M | 89.2M | |
Common Stock Shares Outstanding | 23.7M | 27.2M | 32.2M | 33.4M | 36.5M | 26.9M | |
Long Term Debt Total | 13K | 174.0M | 184.4M | 226.0M | 260.0M | 273.0M | |
Liabilities And Stockholders Equity | 224.3M | 422.5M | 1.3B | 691.2M | 574.1M | 440.0M | |
Non Current Liabilities Total | 2.6M | 184.1M | 245.7M | 230.7M | 268.2M | 206.5M | |
Capital Surpluse | 480.6M | 551.4M | 1.2B | 1.2B | 1.4B | 1.4B | |
Inventory | 129K | 110K | 95K | 80K | 72K | 68.4K | |
Other Current Assets | 5.8M | 5.7M | 8.0M | 8.0M | 6.1M | 5.2M | |
Other Stockholder Equity | 480.6M | 551.4M | 1.2B | 1.2B | 1.2B | 628.4M | |
Total Liab | 81.0M | 265.3M | 573.1M | 479.6M | 439.3M | 342.0M | |
Deferred Long Term Liab | 8.5M | 3.8M | 139K | 198K | 178.2K | 169.3K | |
Property Plant And Equipment Gross | 14.3M | 24.6M | 11.3M | 5.9M | 43.7M | 45.9M | |
Total Current Assets | 195.7M | 385.6M | 358.7M | 250.0M | 223.9M | 213.8M | |
Accumulated Other Comprehensive Income | 1.3M | (192K) | 486K | 5.6M | 2.5M | 1.9M | |
Short Term Debt | 24K | 4.7M | 6.0M | 4.9M | 2.1M | 3.6M | |
Intangible Assets | 4.2M | 6.7M | 138.7M | 73.4M | 59.6M | 35.1M | |
Property Plant Equipment | 14.3M | 13.9M | 21.5M | 5.9M | 6.8M | 12.5M |
Pair Trading with Cardlytics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardlytics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardlytics will appreciate offsetting losses from the drop in the long position's value.Moving together with Cardlytics Stock
0.66 | SE | Sea Financial Report 21st of May 2024 | PairCorr |
Moving against Cardlytics Stock
0.83 | UONEK | Urban One Class Report 4th of July 2024 | PairCorr |
0.81 | LPTV | Loop Media Financial Report 9th of May 2024 | PairCorr |
0.78 | EVC | Entravision Communications Financial Report 2nd of May 2024 | PairCorr |
0.77 | WMG | Warner Music Group Financial Report 14th of May 2024 | PairCorr |
0.74 | IAS | Integral Ad Science Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to Cardlytics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardlytics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardlytics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardlytics to buy it.
The correlation of Cardlytics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardlytics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardlytics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardlytics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Cardlytics Stock analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Cardlytics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardlytics. If investors know Cardlytics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardlytics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.57) | Earnings Share (3.69) | Revenue Per Share 8.474 | Quarterly Revenue Growth 0.081 | Return On Assets (0.06) |
The market value of Cardlytics is measured differently than its book value, which is the value of Cardlytics that is recorded on the company's balance sheet. Investors also form their own opinion of Cardlytics' value that differs from its market value or its book value, called intrinsic value, which is Cardlytics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardlytics' market value can be influenced by many factors that don't directly affect Cardlytics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardlytics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardlytics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardlytics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.